According to a comprehensive analytical report released by Future Market Insights, the global drug discovery informatics market is on the brink of substantial expansion. Projections indicate a meteoric rise from its current valuation of USD 2.9 billion in 2022 to a staggering USD 12.5 billion by 2033, boasting a Compound Annual Growth Rate (CAGR) of 14.4% from 2023 to 2033.
The report identifies Discovery Informatics as the primary driver of this exponential growth, with an anticipated CAGR exceeding 15% during the same period. This revelation underscores the pivotal role informatics plays in reshaping the pharmaceutical and biotechnology industries, particularly in optimizing the drug development process.
Gain Valuable Insights into the Rising Investments and Market Growth of Drug Discovery Informatics Market – Our Sample Report Now
The Drug Discovery Informatics Market stands at the forefront of innovation, leveraging computational tools, software, and data analytics solutions to expedite and enhance the drug discovery and development process. These advancements are crucial in meeting the increasing demand for novel and targeted therapies, driving the integration of informatics to streamline complex workflows in drug research.
As the pharmaceutical and biotechnology industries continue to evolve, the significance of informatics in drug discovery is becoming increasingly evident. Companies operating within this space are poised to capitalize on the growing demand for efficient and effective solutions that accelerate the pace of drug development while ensuring regulatory compliance and safety standards.
With the projected growth trajectory of the global drug discovery informatics industry, stakeholders are urged to stay abreast of market trends and technological advancements to capitalize on emerging opportunities and drive innovation in the quest for improved healthcare outcomes.
Key Factors Driving the Market:
- Increasing Complexity of Drug Discovery: The drug discovery process involves a vast amount of data from various sources, including genomics, proteomics, and chemical libraries. Informatics tools help in managing and analyzing this data effectively.
- Rising R&D Costs: The cost of developing a new drug is substantial, and pharmaceutical companies are under pressure to optimize their R&D processes. Drug discovery informatics offers ways to improve efficiency and reduce costs.
- Advancements in Computational Methods: The growth of computational power and sophisticated algorithms has enabled more accurate simulations and predictions, reducing the need for extensive laboratory testing.
- Personalized Medicine: The trend towards personalized medicine requires tailoring treatments to individual patient characteristics. Informatics helps in identifying patient subgroups that may respond differently to treatments.
- Big Data and Omics Data Integration: The availability of vast amounts of biological and chemical data requires advanced informatics tools to integrate, analyze, and extract meaningful insights.
- Drug Repurposing: Informatics tools can assist in identifying existing drugs that might be repurposed for new therapeutic indications, saving time and resources.
Key Takeaways:
- The largest market, with a value of USD 4.1 billion, is anticipated to be in the United States by the end of 2033. From 2015 to 2022, it expanded at a considerable CAGR of 12.3%; going forward, it is anticipated to increase at a CAGR of 14.4%. One of the factors propelling the Drug Discovery Informatics market in the region is a rising emphasis on data-driven solutions by biotech and pharmaceutical firms.
- By 2033, the market in the United Kingdom is projected to be worth USD 669 million, expanding at a CAGR of 16% between 2023 and 2033. During the projection period, the market is expected to generate an absolute dollar opportunity of USD 514 million.
- By 2033, the market in Japan is projected to be worth USD 731 million. The market in the nation is anticipated to generate an absolute dollar potential of USD 597 million during the forecast period, expanding at a CAGR of 18.7%.
- From 2023 to 2033, the market in South Korea is anticipated to expand at a CAGR of 12.8%. The industry is anticipated to see an absolute dollar potential of USD 194 million during this time and reach USD 275 million by 2033.
Get Full Report Access Elevate Your Business Strategy
Competitive Analysis:
- Certara
- Boehringer Ingelheim International GmbH
- Infosys Ltd.
- Charles River Laboratories
- Collaborative Drug Discovery, Inc.
- Eurofins DiscoverX Products
- Jubilant Biosys
- Selvita
- Novo Informatics Pvt. Ltd.
- ChemAxon Ltd.
- Albany Molecular Research Inc.
- Oracle
- Accenture
- Agilent Technologies, Inc.
- Illumina, Inc.
Some of the recent developments of key Drug Discovery Informatics providers are as follows:
- In April 2022, Iktos, a provider of Artificial Intelligence for new drug design announced their collaboration with Teijin Pharma Limited to evolve Artificial Intelligence for small molecules drug discovery.
- In January 2022, Shanghai Fosun Pharmaceutical collaborated with Insilico Medicine for the discovery and development of drugs utilizing AI technology.
Segments Covered in Drug Discovery Informatics Market Analysis:
By Technique:
- Discovery Informatics
- Identification, Validation, & Assay Development Informatics
- Lead Generation
- Enzymes
- Other Cleanings
- Development Informatics
- Lead Optimization
- FHD Preparation
- Phase IA
- Phase IB/2
By Mode:
- Outsourced
- In-house
By Services:
- Sequence Analysis Platforms
- Molecular Modelling
- Docking
- Clinical Trial Data Management
- Other Services
By Region:
- North America
- Latin America
- Europe
- APAC
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube